Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs.
Chiu Wai Shirley ChanCheong Kay TeoPhilip Hei LiKui Kai LauChak Sing LauHo Yin ChungPublished in: Therapeutic advances in musculoskeletal disease (2021)
SpA is an independent CVS risk factor. Anti-tumor necrosis factor (TNF) drugs were associated with a reduced CVS risk in these patients.